FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W112714802> ?p ?o ?g. }

• W112714802 endingPage "1529.e1" @default.
• W112714802 startingPage "1526" @default.
• W112714802 abstract "To review the clinical features, disease progression, and effects of treatment on idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN).Retrospective interventional case series.Ten patients with IRVAN originally reported in 1995 and 12 additional patients identified since the original series.Patients in the series had testing that may have included fluorescein angiography, indocyanine green angiography, and systemic evaluation. Treatments included panretinal laser photocoagulation, cryotherapy, vitrectomy surgery, and injection of periocular or intravitreal steroids.Initial visual acuity (VA), initial stage at diagnosis, clinical course, surgical intervention, final VA, and complications of disease.A total of 44 eyes of 22 patients were studied; 9 eyes had reached stage 1 or 2 disease at last follow-up, 17 had reached stage 3, and 12 had reached stage 4 or 5. At the time of last follow-up, 14 eyes had maintained 20/20 vision, 15 had between 20/40 and 20/200 vision, and 9 had 20/300 vision or worse. Later stages of retinal ischemia are associated with worse VA. Thirty-two of 38 followed eyes were treated. Twenty-five were treated initially with panretinal laser photocoagulation. The clinical course of each eye after initiation of panretinal laser photocoagulation was evaluated with respect to the final VA and stage of ischemic retinopathy at the initiation of treatment. Panretinal laser photocoagulation was initiated in 3 eyes at stage 2, 16 at stage 3, 5 at stage 4, and 1 at stage 5. Seven eyes underwent grid laser retinal photocoagulation of the macula for macular edema.Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis is an isolated retinal vascular disease that can progress rapidly to severe vision loss due to ischemic sequelae despite treatment with panretinal laser photocoagulation. Based on our review of the largest cohort of IRVAN patients, early panretinal laser photocoagulation should be considered when angiographic evidence of widespread retinal nonperfusion is present, and before (or shortly after) the development of neovascularization. A functional staging system is proposed to improve treatment paradigms." @default.
• W112714802 created "2016-06-24" @default.
• W112714802 creator A5006444304 @default.
• W112714802 creator A5022846317 @default.
• W112714802 creator A5061503632 @default.
• W112714802 creator A5062489830 @default.
• W112714802 creator A5063091648 @default.
• W112714802 creator A5072901569 @default.
• W112714802 creator A5078583592 @default.
• W112714802 date "2007-08-01" @default.
• W112714802 modified "2023-10-01" @default.
• W112714802 title "Idiopathic Retinitis, Vasculitis, Aneurysms, and Neuroretinitis (IRVAN)" @default.
• W112714802 cites W1971050235 @default.
• W112714802 cites W1984974163 @default.
• W112714802 cites W2074782134 @default.
• W112714802 cites W2416146661 @default.
• W112714802 cites W4253140586 @default.
• W112714802 doi "https://doi.org/10.1016/j.ophtha.2006.11.014" @default.
• W112714802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17678691" @default.
• W112714802 hasPublicationYear "2007" @default.
• W112714802 type Work @default.
• W112714802 sameAs 112714802 @default.
• W112714802 citedByCount "108" @default.
• W112714802 countsByYear W1127148022012 @default.
• W112714802 countsByYear W1127148022013 @default.
• W112714802 countsByYear W1127148022014 @default.
• W112714802 countsByYear W1127148022015 @default.
• W112714802 countsByYear W1127148022016 @default.
• W112714802 countsByYear W1127148022017 @default.
• W112714802 countsByYear W1127148022018 @default.
• W112714802 countsByYear W1127148022019 @default.
• W112714802 countsByYear W1127148022020 @default.
• W112714802 countsByYear W1127148022021 @default.
• W112714802 countsByYear W1127148022022 @default.
• W112714802 countsByYear W1127148022023 @default.
• W112714802 crossrefType "journal-article" @default.
• W112714802 hasAuthorship W112714802A5006444304 @default.
• W112714802 hasAuthorship W112714802A5022846317 @default.
• W112714802 hasAuthorship W112714802A5061503632 @default.
• W112714802 hasAuthorship W112714802A5062489830 @default.
• W112714802 hasAuthorship W112714802A5063091648 @default.
• W112714802 hasAuthorship W112714802A5072901569 @default.
• W112714802 hasAuthorship W112714802A5078583592 @default.
• W112714802 hasConcept C118487528 @default.
• W112714802 hasConcept C126322002 @default.
• W112714802 hasConcept C141071460 @default.
• W112714802 hasConcept C146357865 @default.
• W112714802 hasConcept C151730666 @default.
• W112714802 hasConcept C159047783 @default.
• W112714802 hasConcept C2522874641 @default.
• W112714802 hasConcept C2775955145 @default.
• W112714802 hasConcept C2776015282 @default.
• W112714802 hasConcept C2777016524 @default.
• W112714802 hasConcept C2777104736 @default.
• W112714802 hasConcept C2778257484 @default.
• W112714802 hasConcept C2778328719 @default.
• W112714802 hasConcept C2779134260 @default.
• W112714802 hasConcept C2779820661 @default.
• W112714802 hasConcept C2780149145 @default.
• W112714802 hasConcept C2780248432 @default.
• W112714802 hasConcept C2780347916 @default.
• W112714802 hasConcept C2781242345 @default.
• W112714802 hasConcept C71924100 @default.
• W112714802 hasConcept C86803240 @default.
• W112714802 hasConceptScore W112714802C118487528 @default.
• W112714802 hasConceptScore W112714802C126322002 @default.
• W112714802 hasConceptScore W112714802C141071460 @default.
• W112714802 hasConceptScore W112714802C146357865 @default.
• W112714802 hasConceptScore W112714802C151730666 @default.
• W112714802 hasConceptScore W112714802C159047783 @default.
• W112714802 hasConceptScore W112714802C2522874641 @default.
• W112714802 hasConceptScore W112714802C2775955145 @default.
• W112714802 hasConceptScore W112714802C2776015282 @default.
• W112714802 hasConceptScore W112714802C2777016524 @default.
• W112714802 hasConceptScore W112714802C2777104736 @default.
• W112714802 hasConceptScore W112714802C2778257484 @default.
• W112714802 hasConceptScore W112714802C2778328719 @default.
• W112714802 hasConceptScore W112714802C2779134260 @default.
• W112714802 hasConceptScore W112714802C2779820661 @default.
• W112714802 hasConceptScore W112714802C2780149145 @default.
• W112714802 hasConceptScore W112714802C2780248432 @default.
• W112714802 hasConceptScore W112714802C2780347916 @default.
• W112714802 hasConceptScore W112714802C2781242345 @default.
• W112714802 hasConceptScore W112714802C71924100 @default.
• W112714802 hasConceptScore W112714802C86803240 @default.
• W112714802 hasIssue "8" @default.
• W112714802 hasLocation W1127148021 @default.
• W112714802 hasLocation W1127148022 @default.
• W112714802 hasOpenAccess W112714802 @default.
• W112714802 hasPrimaryLocation W1127148021 @default.
• W112714802 hasRelatedWork W112714802 @default.
• W112714802 hasRelatedWork W2080574659 @default.
• W112714802 hasRelatedWork W2333079519 @default.
• W112714802 hasRelatedWork W2382271908 @default.
• W112714802 hasRelatedWork W2385085536 @default.
• W112714802 hasRelatedWork W3031867745 @default.
• W112714802 hasRelatedWork W3032833342 @default.
• W112714802 hasRelatedWork W3043566990 @default.

• next